ageas SA/NV (EBR:AGS)
Belgium · Delayed Price · Currency is EUR 66.70
+0.15 (0.23%)
Apr 30, 2026, 5:36 PM CET
ageas Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 7,850 | 7,050 | 6,191 | 5,909 | 8,533 |
Total Interest & Dividend Income | 2,050 | 2,372 | 2,279 | -922 | 2,601 |
Gain (Loss) on Sale of Investments | 124 | 144 | 147 | 98 | 1,358 |
Other Revenue | -595 | -1,056 | -1,088 | 1,906 | 967 |
| 9,429 | 8,510 | 7,529 | 6,991 | 13,459 | |
Revenue Growth (YoY) | 10.80% | 13.03% | 7.70% | -48.06% | 12.65% |
Policy Benefits | 5,395 | 4,819 | 4,150 | 4,095 | 9,043 |
Policy Acquisition & Underwriting Costs | 1,181 | 1,079 | 960 | 958 | 1,213 |
Selling, General & Administrative | 131 | 116 | 93 | 86 | 157 |
Provision for Bad Debts | - | - | - | - | 3 |
Other Operating Expenses | 1,698 | 1,500 | 1,284 | 1,121 | 978 |
Total Operating Expenses | 8,428 | 7,534 | 6,511 | 6,266 | 12,241 |
Operating Income | 1,001 | 976 | 1,018 | 725 | 1,218 |
Interest Expense | -240 | -241 | -231 | -134 | -121 |
Earnings From Equity Investments | 1,123 | 564 | 439 | 508 | - |
Other Non Operating Income (Expenses) | 435 | 318 | 234 | 398 | -15 |
EBT Excluding Unusual Items | 2,319 | 1,617 | 1,460 | 1,497 | 1,082 |
Merger & Restructuring Charges | -6 | - | - | - | - |
Impairment of Goodwill | -137 | -7 | -7 | -1 | -2 |
Gain (Loss) on Sale of Assets | - | - | - | - | 136 |
Asset Writedown | -4 | -20 | -35 | -6 | - |
Legal Settlements | - | -15 | 10 | -1 | 15 |
Pretax Income | 2,172 | 1,575 | 1,428 | 1,489 | 1,231 |
Income Tax Expense | 262 | 266 | 251 | 205 | 215 |
Earnings From Continuing Ops. | 1,910 | 1,309 | 1,177 | 1,284 | 1,016 |
Minority Interest in Earnings | -198 | -191 | -224 | -187 | -171 |
Net Income | 1,712 | 1,118 | 953 | 1,097 | 845 |
Net Income to Common | 1,712 | 1,118 | 953 | 1,097 | 845 |
Net Income Growth | 53.13% | 17.31% | -13.13% | 29.82% | -25.94% |
Shares Outstanding (Basic) | 188 | 183 | 184 | 184 | 187 |
Shares Outstanding (Diluted) | 188 | 184 | 184 | 184 | 187 |
Shares Change (YoY) | 2.54% | -0.13% | -0.27% | -1.38% | -0.63% |
EPS (Basic) | 9.10 | 6.10 | 5.19 | 5.96 | 4.52 |
EPS (Diluted) | 9.09 | 6.09 | 5.19 | 5.95 | 4.52 |
EPS Growth | 49.26% | 17.37% | -12.80% | 31.64% | -25.41% |
Free Cash Flow | 2,711 | 802 | -25 | 937 | -1,115 |
Free Cash Flow Per Share | 14.40 | 4.37 | -0.14 | 5.08 | -5.97 |
Dividend Per Share | 3.750 | 3.500 | 3.250 | 3.000 | 2.750 |
Dividend Growth | 7.14% | 7.69% | 8.33% | 9.09% | 3.77% |
Operating Margin | 10.62% | 11.47% | 13.52% | 10.37% | 9.05% |
Profit Margin | 18.16% | 13.14% | 12.66% | 15.69% | 6.28% |
Free Cash Flow Margin | 28.75% | 9.42% | -0.33% | 13.40% | -8.28% |
EBITDA | 1,264 | 1,204 | 1,049 | 1,030 | 1,537 |
EBITDA Margin | 13.41% | 14.15% | 13.93% | 14.73% | 11.42% |
D&A For EBITDA | 263 | 228 | 31 | 305 | 319 |
EBIT | 1,001 | 976 | 1,018 | 725 | 1,218 |
EBIT Margin | 10.62% | 11.47% | 13.52% | 10.37% | 9.05% |
Effective Tax Rate | 12.06% | 16.89% | 17.58% | 13.77% | 17.46% |
Revenue as Reported | - | - | - | - | 13,772 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.